Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Hypersensitivity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05098821
What this trial is testing

Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation

Who this might be right for
Atopic Dermatitis
Charite University, Berlin, Germany 25
Not applicableNot Yet RecruitingNCT06174493
What this trial is testing

Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials

Who this might be right for
Atopic Dermatitis
Power Life Sciences Inc. 500
Early research (Phase 1)Study completedNCT02219633
What this trial is testing

Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
LEO Pharma 30
Testing effectiveness (Phase 2)Study completedNCT02475447
What this trial is testing

Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis

Who this might be right for
PruritusAtopic Dermatitis
Tioga Pharmaceuticals 249
Not applicableEnded earlyNCT01402414
What this trial is testing

Narrow-band (NB)-UVB vs. Bath-PUVA and NB-UVB Plus Salt Water Baths in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Ruhr University of Bochum 10
Large-scale testing (Phase 3)Study completedNCT05571943
What this trial is testing

Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Acrotech Biopharma Inc. 542
Not applicableStudy completedNCT07428915
What this trial is testing

Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists

Who this might be right for
Pustular Psoriasis (PP)Generalized Pustular Psoriasis (GPP)Eczema Atopic Dermatitis+11 more
AI Labs Group S.L 15
Not applicableStudy completedNCT04476433
What this trial is testing

Intervention in Chronic Pediatric Patients and Their Families.

Who this might be right for
Type 1 DiabetesAllergic RhinitisAllergic Asthma+8 more
University of Valencia 500
Testing effectiveness (Phase 2)Study completedNCT04530643
What this trial is testing

A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon)

Who this might be right for
Atopic Dermatitis
Shaperon 80
Testing effectiveness (Phase 2)Study completedNCT03381625
What this trial is testing

Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis

Who this might be right for
PsoriasisAtopic Dermatitis
BioMimetix JV, LLC 139
Not applicableEnded earlyNCT05250115
What this trial is testing

Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 112
Not applicableUnknownNCT04445298
What this trial is testing

Skin Barrier Assessment in Pregnancy and at Birth

Who this might be right for
Pregnancy RelatedAllergyAtopic Dermatitis Eczema+2 more
National Jewish Health 160
Not applicableStudy completedNCT05214326
What this trial is testing

Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf Countries

Who this might be right for
Dermatitis Atopic
Sanofi 187
Early research (Phase 1)Study completedNCT07336940
What this trial is testing

Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Enveda Therapeutics 9
Early research (Phase 1)WithdrawnNCT01368315
What this trial is testing

CT 327 in the "Atopy Patch Test" Model

Who this might be right for
Atopic Dermatitis
Creabilis SA 20
Not applicableLooking for participantsNCT03549416
What this trial is testing

BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
UMC Utrecht 1,200
Not applicableLooking for participantsNCT07832643
What this trial is testing

Primary Allergy and Its Impact on the Occurrence of Respiratory Distress in Infants at 12 Months of Age

Who this might be right for
AllergyRespiratory DistressAtopic Manifestations+1 more
Centre Hospitalier Universitaire, Amiens 508
Large-scale testing (Phase 3)Study completedNCT00523952
What this trial is testing

Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients

Who this might be right for
Dermatitis, Atopic
Astellas Pharma Inc 303
Not applicableLooking for participantsNCT06182436
What this trial is testing

Virtual Reality for Pain Management During Dupilumab Injection

Who this might be right for
Atopic DermatitisPainAnxiety
St. Justine's Hospital 98
Post-approval studies (Phase 4)Not Yet RecruitingNCT07438509
What this trial is testing

Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema

Who this might be right for
Atopic Dermatitis (AD)Atopic Eczema
Jinnah Postgraduate Medical Centre 270
Next Page